Yang Xiaojun, Zhan Chaoning, Cheng Tianjiao, Huang Minchun, Ge Weiwen, Zhang Yiqing, Chen Ting, Lu Yanli, Cui Zhong-Kai, Hou Jin
Department of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Department of Cell Biology, School of Basic Medical Sciences, Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Southern Medical University, Guangzhou, China.
Int Endod J. 2023 Feb;56(2):245-258. doi: 10.1111/iej.13865. Epub 2022 Nov 13.
Dentinal tubules serve as disease-causing channels for infiltration and penetration of bacteria and their by-products; which are regarded as the major driver of pathogenesis in pulpal inflammation and infection. In this study, we aimed to evaluate the transdentinal potential of nanoscale cetylpyridinium chloride/cholesterol (CPC/Chol) sterosomes, which are a recently developed type of cationic non-phospholipid liposomal nanocarrier; as well as their intrinsic and universal antibacterial activity.
Cetylpyridinium chloride/cholesterol sterosomes were formulated, with a hydrodynamic diameter of 134 ± 4 nm, a low polydisperse index of 0.161 ± 0.007, and a positive zeta potential of 41 ± 3 mV at pH 7.4. Transdentinal diffusion ability of sterosomes was evaluated using human dentine blocks in vitro, and Wistar rat molar teeth in vivo. The intrinsic antibacterial activities of CPC/Chol sterosomes against Enterococcus faecalis, Streptococcus mutans, Fusobacterium nucleatum, and Porphyromonas gingivalis were further examined.
Cetylpyridinium chloride/cholesterol sterosomes successfully penetrated through the dentinal tubules, and diffused into the pulp, which could be internalized by dental pulp cells with a high efficiency. In addition, they exhibited substantial levels of intrinsic antibacterial activity against these Gram-positive and Gram-negative endodontic bacteria and their biofilms.
Given its high penetration and diffusion ability through the dentine and pulp, great potential for multi-drug delivery, and distinct intrinsic antibacterial activity; sterosome-based nanocarriers might serve as a promising therapeutic strategy aimed at targeting various specific pathways associated with pulpal diseases. This will help determine and characterize the most appropriate prophylactic and therapeutic targets for early intervention in our future dentistry practice.
牙本质小管是细菌及其副产物渗入和穿透的致病通道;被认为是牙髓炎症和感染发病机制的主要驱动因素。在本研究中,我们旨在评估纳米级十六烷基氯化吡啶鎓/胆固醇(CPC/Chol)脂质体,这是一种最近开发的阳离子非磷脂脂质体纳米载体的经牙本质渗透潜力;以及它们固有的和普遍的抗菌活性。
制备十六烷基氯化吡啶鎓/胆固醇脂质体,其流体动力学直径为134±4nm,多分散指数低,为0.161±0.007,在pH 7.4时zeta电位为正41±3mV。使用人牙本质块在体外和Wistar大鼠磨牙在体内评估脂质体的经牙本质扩散能力。进一步检测CPC/Chol脂质体对粪肠球菌、变形链球菌、具核梭杆菌和牙龈卟啉单胞菌的固有抗菌活性。
十六烷基氯化吡啶鎓/胆固醇脂质体成功穿透牙本质小管并扩散到牙髓中,牙髓细胞可高效摄取。此外,它们对这些革兰氏阳性和革兰氏阴性牙髓细菌及其生物膜表现出显著的固有抗菌活性。
鉴于其通过牙本质和牙髓的高渗透和扩散能力、多药物递送的巨大潜力以及独特的固有抗菌活性;基于脂质体的纳米载体可能是一种有前景的治疗策略,旨在针对与牙髓疾病相关的各种特定途径。这将有助于确定和表征最合适的预防和治疗靶点,以便在未来的牙科实践中进行早期干预。